Design, Synthesis and Antitumor Activity of Novel Selenium-Containing Tepotinib Derivatives as Dual Inhibitors of c-Met and TrxR

Cellular mesenchymal–epithelial transition factor (c-Met), an oncogenic transmembrane receptor tyrosine kinase (RTK), plays an essential role in cell proliferation during embryo development and liver regeneration. Thioredoxin reductase (TrxR) is overexpressed and constitutively active in most tumors...

Full description

Bibliographic Details

Published in:	Molecules
Main Authors:	Jinhui Hu, Li Chen, Zhonghui Lu, Han Yao, Yunfei Hu, Luanqi Feng, Yanqing Pang, Jia-Qiang Wu, Zhiling Yu, Wen-Hua Chen
Format:	Article
Language:	English
Published:	MDPI AG 2023-01-01
Subjects:	dual target anticancer agent c-Met inhibitor TrxR inhibitor
Online Access:	https://www.mdpi.com/1420-3049/28/3/1304